These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11913094)

  • 1. [New active agents. The composition of commercial pharmaceutical specialties in 2001].
    Bernard M
    J Pharm Belg; 2002; 57(1):1-13. PubMed ID: 11913094
    [No Abstract]   [Full Text] [Related]  

  • 2. [New active agents approved as pharmaceutical specialties in 2002].
    Bernard M
    J Pharm Belg; 2003; 58(1):1-20. PubMed ID: 12722540
    [No Abstract]   [Full Text] [Related]  

  • 3. [A survey of some new pharmaceutical specialties introduced in Belgium in 2003].
    Masereel B
    J Pharm Belg; 2004; 59(1):1-12. PubMed ID: 15129574
    [No Abstract]   [Full Text] [Related]  

  • 4. Pipelines turn to biotech.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015
    [No Abstract]   [Full Text] [Related]  

  • 5. Trading on traditional medicines.
    Basu P
    Nat Biotechnol; 2004 Mar; 22(3):263-5. PubMed ID: 14990941
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quality control of drugs and drug specialties].
    Meyrat A
    Pharm Acta Helv; 1967 Jan; 42(1):14-36. PubMed ID: 6043416
    [No Abstract]   [Full Text] [Related]  

  • 8. High-throughput screening. Advances in robotics and miniturization continue to accelerate drug lead identification.
    Persidis A
    Nat Biotechnol; 1998 May; 16(5):488-9. PubMed ID: 9592401
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharma faces major challenges after a year of failures and heated battles.
    Frantz S
    Nat Rev Drug Discov; 2007 Jan; 6(1):5-7. PubMed ID: 17269157
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in antimicrobial drug development: implications for the future.
    Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
    Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The year's new drugs & biologics - 2008.
    Graul AI; Revel L; Barrionuevo M; Cruces E; Rosa E; Verges C; Lupone B; Diaz N; Castaner R
    Drug News Perspect; 2009; 22(1):7-29. PubMed ID: 19209296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The year's new drugs and biologics--2007.
    Graul AI; Prous JR; Barrionuevo M; Bozzo J; Castaner R; Cruces E; Revel L; Rosa E; Serradell N; Sorbera LA
    Drug News Perspect; 2008; 21(1):7-35. PubMed ID: 18301807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceuticals: recent approvals and likely directions.
    Walsh G
    Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena.
    Ramanathan R; Korfmacher W
    Bioanalysis; 2012 Mar; 4(5):467-9. PubMed ID: 22409544
    [No Abstract]   [Full Text] [Related]  

  • 16. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 18. Issues in bringing new drugs to the market.
    Tracey WR
    Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329172
    [No Abstract]   [Full Text] [Related]  

  • 19. [Czechoslovak mass-produced pharmaceutical preparations--their number and internal composition. IV].
    Dofková L; Precechtĕlová E; Malír F
    Cesk Farm; 1979 Feb; 28(1):6-10. PubMed ID: 455500
    [No Abstract]   [Full Text] [Related]  

  • 20. Issues in bringing new drugs to the market.
    Ansbacher R
    Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16322437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.